Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.
| Title: | Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system. |
|---|---|
| Authors: | Becker J; Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre RS, Brazil.; Ferreira LC; Universidade Federal de Sergipe, Aracaju SE, Brazil.; Universidade Tiradentes, Aracaju SE, Brazil.; Damasceno A; Universidade de Campinas, Faculdade de Ciências Médicas, Campinas SP, Brazil.; Bichuetti DB; Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo SP, Brazil.; Christo PP; Universidade Federal de Minas Gerais, Belo Horizonte MG, Brazil.; Callegaro D; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Peixoto MAL; Universidade Federal de Minas Gerais, Belo Horizonte MG, Brazil.; Sousa NAC; Universidade Federal do Amazonas, Manaus AM, Brazil.; Almeida SM; Universidade Federal do Paraná, Curitiba PR, Brazil.; Adoni T; Hospital Sírio Libanês, São Paulo SP, Brazil.; Santiago-Amaral J; Universidade Federal de Minas Gerais, Belo Horizonte MG, Brazil.; Junqueira T; Escola Bahiana de Medicina e Saúde Pública, Salvador BA, Brazil.; Pereira SLA; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Gomes ABAGR; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Pitombeira M; Hospital Geral de Fortaleza, Fortaleza CE, Brazil.; Paolilo RB; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Grzesiuk AK; Clínica Nossa Senhora das Graças, Cuiabá MS, Brazil.; Piccolo AC; Hospital Santa Marcelina, São Paulo SP, Brazil.; D Almeida JAC; Hospital Geral de Fortaleza, Fortaleza CE, Brazil.; Gomes Neto AP; Santa Casa, Belo Horizonte MG, Brazil.; Oliveira ACP; Instituto de Infectologia Emílio Ribas, São Paulo SP, Brazil.; Oliveira BS; Fundação Centro Integrado de Apoio ao Portador de Deficiência, João Pessoa PB, Brazil.; Tauil CB; Secretaria de Estado da Saúde, Brasília DF, Brazil.; Vasconcelos CF; Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ, Brazil.; Kaimen-Maciel D; Santa Casa, Londrina PR, Brazil.; Varela D; Hospital de Clínicas de Passo Fundo, Passo Fundo RS, Brazil.; Diniz DS; Universidade Federal de Goiás, Goiânia GO, Brazil.; Oliveira EML; Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo SP, Brazil.; Malfetano FR; Universidade Estácio de Sá, Rio de Janeiro RJ, Brazil.; Borges FE; Private Service, Goiânia GO, Brazil.; Figueira FFA; Hospital São Francisco na Providência de Deus, Rio de Janeiro RJ, Brazil.; Gondim FAA; Universidade Federal do Ceará, Fortaleza CE, Brazil.; Passos GRD; Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre RS, Brazil.; Silva GD; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Olival GSD; Associação Brasileira de Esclerose Múltipla, São Paulo SP, Brazil.; Santa Casa, São Paulo SP, Brazil.; Santos GACD; Universidade Estácio de Sá, Rio de Janeiro RJ, Brazil.; Universidade Federal Fluminense, Niterói RJ, Brazil.; Ruocco HH; Universidade Federal Fluminense, Niterói RJ, Brazil.; Pontifícia Universidade Católica, Campina SP, Brazil.; Sato HK; Instituto de Neurologia de Curitiba, Curitiba PR, Brazil.; Soares Neto HR; IAMSPE, São Paulo SP, Brazil.; Cortoni Calia L; Private Service, São Paulo SP, Brazil.; Gonçalves MVM; Universidade da Região de Joinville, Joinville SC, Brazil.; Vecino MCA; Hospital Moinhos de Vento, Porto Alegre RS, Brazil.; Pimentel MLV; Santa Casa, Rio de Janeiro RJ, Brazil.; Ribeiro MC; Universidade Federal Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil.; Boaventura M; Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, São Paulo SP, Brazil.; Parolin MKF; Private Service, Curitiba PR, Brazil.; Melo RBS; Santa Casa, Belo Horizonte MG, Brazil.; Lázaro R; Faculdade de Medicina de Jundiaí, Jundiaí SP, Brazil.; Thomaz RB; Hospital Israelita Albert Einstein, São Paulo SP, Brazil.; Kleinpaul R; Universidade Federal de Minas Gerais, Belo Horizonte MG, Brazil.; Dias RM; Hospital de Base do Distrito Federal, Brasília DF, Brazil.; Gomes S; Hospital Beneficiência Portuguesa, São Paulo SP, Brazil.; Lucatto SA; Hospital Regional de Vilhena, Vilhena RO, Brazil.; Alves-Leon SV; Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro RJ, Brazil.; Fukuda T; Hospital Universitário Prof. Edgar Santos, Salvador BA, Brazil.; Ribeiro TAGJ; Universidade Federal de Goiás, Goiânia GO, Brazil.; Winckler TCD; Private Service, Curitiba PR, Brazil.; Fragoso YD; Universidade Metropolitana de Santos, Santos SP, Brazil.; Nascimento OJMD; Universidade Estácio de Sá, Rio de Janeiro RJ, Brazil.; Universidade Federal Fluminense, Niterói RJ, Brazil.; Ferreira MLB; Hospital da Restauração, Recife PE, Brazil.; Mendes MF; Santa Casa, São Paulo SP, Brazil.; Brum DG; Universidade Estadual Paulista, Faculdade de Medicina de Botucatu, Botucatu SP, Brazil.; Glehn FV; Universidade de Campinas, Faculdade de Ciências Médicas, Campinas SP, Brazil.; Universidade de Brasília, Faculdade de Medicina, Brasília DF, Brazil. |
| Source: | Arquivos de neuro-psiquiatria [Arq Neuropsiquiatr] 2021 Nov; Vol. 79 (11), pp. 1049-1061. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Thieme Country of Publication: Germany NLM ID: 0125444 Publication Model: Print Cited Medium: Internet ISSN: 1678-4227 (Electronic) Linking ISSN: 0004282X NLM ISO Abbreviation: Arq Neuropsiquiatr Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2022- : [Stuttgart] : Thieme; Original Publication: São Paulo. |
| MeSH Terms: | Multiple Sclerosis*/drug therapy ; COVID-19* ; Neurology*; Central Nervous System ; Humans ; SARS-CoV-2 ; Vaccination |
| Abstract: | The Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) provide recommendations in this document for vaccination of the population with demyelinating diseases of the central nervous system (CNS) against infections in general and against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. We emphasize the seriousness of the current situation in view of the spread of COVID-19 in our country. Therefore, reference guides on vaccination for clinicians, patients, and public health authorities are particularly important to prevent some infectious diseases. The DCNI/ABN and BCTRIMS recommend that patients with CNS demyelinating diseases (e.g., MS and NMOSD) be continually monitored for updates to their vaccination schedule, especially at the beginning or before a change in treatment with a disease modifying drug (DMD). It is also important to note that vaccines are safe, and physicians should encourage their use in all patients. Clearly, special care should be taken when live attenuated viruses are involved. Finally, it is important for physicians to verify which DMD the patient is receiving and when the last dose was taken, as each drug may affect the induction of immune response differently. |
| Entry Date(s): | Date Created: 20211124 Date Completed: 20211203 Latest Revision: 20211214 |
| Update Code: | 20260130 |
| DOI: | 10.1590/0004-282X-ANP-2021-0162 |
| PMID: | 34816999 |
| Database: | MEDLINE |
Journal Article